Literature DB >> 16978782

Role of PKA and PKC in histamine H1 receptor-mediated activation of catecholamine neurotransmitter synthesis.

Nader H Moniri1, Raymond G Booth.   

Abstract

Activation of the histamine H1 receptor stimulates tyrosine hydroxylase (TH) to increase catecholamine neurotransmitter synthesis in mammalian brain and adrenal tissues. Histamine non-selectively activates both H1-linked phospholipase (PL) C/inositol phosphates (IP)/diacylglycerol (DAG) signaling and adenylyl cyclase (AC)/adenosine 3',5'-cyclic monophosphate (cAMP) signaling, confounding determination of signaling events involved in H(1)-mediated TH activation. This research uses two new functionally-selective H1 agonists, cis-PAB and trans-PAT, that selectively activate H1/PLC/IP/DAG and H1/AC/cAMP signaling, respectively, to characterize H(1)-mediated activation of TH in rat striatum and bovine adrenal chromaffin (BAC) cells. Histamine, cis-PAB, and trans-PAT produced a two-fold maximal TH activation by an H1 receptor mechanism in rat striatum and BAC cells. Histamine is more potent and efficacious in BAC cells (EC50 approximately 0.2 microM, Emax approximately 200% basal) versus rat striatum (EC50 approximately 0.4 microM; Emax approximately 150%). Cis-PAB and trans-PAT are more potent in rat striatum (EC50 approximately 0.1 microM for both agonists) versus BAC cells (EC50 approximately 1.0 microM for both), with similar efficacy in both preparations (Emax approximately 160% for both agonists). Signaling studies in BAC cells revealed that protein kinase (PK) A but not PKC is involved in H1 -mediated TH activation by trans-PAT and histamine, while, both PKA and PKC are involved for cis-PAB. Results for cis-PAB suggest H1/PLC/IP/DAG/PKC signaling activates PKA, downstream of cAMP formation, indicating apparent direct activation of PKA by PKC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978782     DOI: 10.1016/j.neulet.2006.08.051

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Molecular determinants of ligand-directed signaling for the histamine H1 receptor.

Authors:  R G Booth; L Fang; A Wilczynski; S Sivendren; Z Sun; S Travers; M Bruysters; K Sansuk; R Leurs
Journal:  Inflamm Res       Date:  2008       Impact factor: 4.575

2.  A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.

Authors:  Nadine S Jahchan; Joel T Dudley; Pawel K Mazur; Natasha Flores; Dian Yang; Alec Palmerton; Anne-Flore Zmoos; Dedeepya Vaka; Kim Q T Tran; Margaret Zhou; Karolina Krasinska; Jonathan W Riess; Joel W Neal; Purvesh Khatri; Kwon S Park; Atul J Butte; Julien Sage
Journal:  Cancer Discov       Date:  2013-09-26       Impact factor: 39.397

3.  (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.

Authors:  Raymond G Booth; Lijuan Fang; Yingsu Huang; Andrzej Wilczynski; Sashikala Sivendran
Journal:  Eur J Pharmacol       Date:  2009-05-03       Impact factor: 4.432

4.  Modulation of Dendritic Cell Apoptosis and CD8+ Cytotoxicity by Histamine: Role of Protein Kinase C.

Authors:  Julieta Alcain; Enrique Podaza; María Soledad Gori; Gabriela Salamone; Mónica Vermeulen
Journal:  Mediators Inflamm       Date:  2017-08-29       Impact factor: 4.711

5.  Allergic manifestations and cutaneous histamine responses in patients with McCune Albright syndrome.

Authors:  Jill D Jacobson; Angela L Turpin; Scott A Sands
Journal:  World Allergy Organ J       Date:  2013-05-01       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.